NYSE:CO - Global Cord Blood Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $6.26 -0.21 (-3.25 %) (As of 05/24/2019 02:47 AM ET)Previous Close$6.47Today's Range$6.21 - $6.4852-Week Range$5.67 - $10.12Volume223,800 shsAverage Volume63,168 shsMarket Capitalization$760.91 millionP/E Ratio23.43Dividend Yield1.24%Beta0.38 ProfileChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2018, it had three operating cord blood banks in the Beijing municipality, the Guangdong province, and the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation is a subsidiary of Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (Limited Partnership). Receive CO News and Ratings via Email Sign-up to receive the latest news and ratings for CO and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Holding & other investment offices Sub-IndustryN/A SectorMedical Current SymbolNYSE:CO Previous Symbol CUSIPN/A CIK1467808 Webhttp://www.globalcordbloodcorp.com/ Phone852-3605-8180Debt Debt-to-Equity RatioN/A Current Ratio9.65 Quick Ratio9.61Price-To-Earnings Trailing P/E Ratio23.43 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$149.34 million Price / Sales5.10 Cash Flow$0.3637 per share Price / Cash Flow17.21 Book Value$4.12 per share Price / Book1.52Profitability EPS (Most Recent Fiscal Year)N/A Net Income$37.79 million Net Margins23.64% Return on Equity7.10% Return on Assets3.75%Miscellaneous Employees1,196 Outstanding Shares121,551,000Market Cap$760.91 million Next Earnings Date6/25/2019 (Estimated) OptionableOptionable Global Cord Blood (NYSE:CO) Frequently Asked Questions What is Global Cord Blood's stock symbol? Global Cord Blood trades on the New York Stock Exchange (NYSE) under the ticker symbol "CO." How often does Global Cord Blood pay dividends? What is the dividend yield for Global Cord Blood? Global Cord Blood announced an annual dividend on Tuesday, June 26th. Shareholders of record on Monday, July 30th will be given a dividend of $0.08 per share on Monday, August 20th. This represents a yield of 0.93%. The ex-dividend date is Friday, July 27th. View Global Cord Blood's Dividend History. How were Global Cord Blood's earnings last quarter? Global Cord Blood Corp (NYSE:CO) posted its quarterly earnings results on Monday, February, 25th. The medical research company reported $0.07 EPS for the quarter. The medical research company had revenue of $36.97 million for the quarter. Global Cord Blood had a return on equity of 7.10% and a net margin of 23.64%. View Global Cord Blood's Earnings History. When is Global Cord Blood's next earnings date? Global Cord Blood is scheduled to release their next quarterly earnings announcement on Tuesday, June 25th 2019. View Earnings Estimates for Global Cord Blood. Has Global Cord Blood been receiving favorable news coverage? Media headlines about CO stock have been trending very negative on Friday, according to InfoTrie Sentiment. The research group ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Global Cord Blood earned a coverage optimism score of -3.0 on InfoTrie's scale. They also assigned press coverage about the medical research company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the near future. Who are some of Global Cord Blood's key competitors? Some companies that are related to Global Cord Blood include Verra Mobility (VRRM), Bain Capital Specialty Finance (BCSF), CHURCHILL CAP C/SH (CCC), GS ACQUISITION /SH CL A (GSAH), Vantage Energy Acquisition (VEAC), HAYMAKER ACQUIS/SH CL A (HYAC), Pensare Acquisition (WRLS), THUNDER BRDG AC/SH SH (TBRG), FORUM MERGER II/SH CL A (FMCI), ANDINA ACQUISIT/SH SH (ANDA), AgroFresh Solutions (AGFS), KBL MERGER CORP/SH (KBLM), Jetpay (JTPY), CM SEVEN STAR A/SH SH (CMSS) and Alta Mesa Resources (AMR). What other stocks do shareholders of Global Cord Blood own? Based on aggregate information from My MarketBeat watchlists, some companies that other Global Cord Blood investors own include Galectin Therapeutics (GALT), Micron Technology (MU), AEterna Zentaris (AEZS), Arotech (ARTX), Exelixis (EXEL), Eyepoint Pharmaceuticals (EYPT), Fate Therapeutics (FATE), Immunomedics (IMMU), Madrigal Pharmaceuticals (MDGL) and Marvell Technology Group (MRVL). Who are Global Cord Blood's key executives? Global Cord Blood's management team includes the folowing people: Ms. Ting Zheng, Chairman, CEO & Interim CEO of Beijing Division (Age 47)Mr. Albert Chen, CFO & Director (Age 43)Ms. Xin Xu, Chief Technology Officer (Age 65)Ms. Rui Arashiyama, Chief Exec. Officer of Guangdong Division & Zhejiang Division (Age 60)Ms. Cathy Bai, VP of Corp. Fin. Who are Global Cord Blood's major shareholders? Global Cord Blood's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Jayhawk Capital Management L.L.C. (11.05%), Renaissance Technologies LLC (2.30%), Man Group plc (0.58%), Oxford Asset Management LLP (0.10%), SG Americas Securities LLC (0.09%) and Parametric Portfolio Associates LLC (0.06%). View Institutional Ownership Trends for Global Cord Blood. Which institutional investors are selling Global Cord Blood stock? CO stock was sold by a variety of institutional investors in the last quarter, including Man Group plc and California Public Employees Retirement System. View Insider Buying and Selling for Global Cord Blood. Which institutional investors are buying Global Cord Blood stock? CO stock was bought by a variety of institutional investors in the last quarter, including Jayhawk Capital Management L.L.C., Renaissance Technologies LLC, SG Americas Securities LLC, Oxford Asset Management LLP, Lingohr & Partner Asset Management GmbH, JPMorgan Chase & Co. and Parametric Portfolio Associates LLC. View Insider Buying and Selling for Global Cord Blood. How do I buy shares of Global Cord Blood? Shares of CO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Global Cord Blood's stock price today? One share of CO stock can currently be purchased for approximately $6.26. How big of a company is Global Cord Blood? Global Cord Blood has a market capitalization of $760.91 million and generates $149.34 million in revenue each year. Global Cord Blood employs 1,196 workers across the globe. What is Global Cord Blood's official website? The official website for Global Cord Blood is http://www.globalcordbloodcorp.com/. How can I contact Global Cord Blood? Global Cord Blood's mailing address is 48 FL. BANK OF CHINA TOWER 1 GARDEN ROAD, HONG KONG K3, . The medical research company can be reached via phone at 852-3605-8180 or via email at [email protected] MarketBeat Community Rating for Global Cord Blood (NYSE CO)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 186 (Vote Outperform)Underperform Votes: 207 (Vote Underperform)Total Votes: 393MarketBeat's community ratings are surveys of what our community members think about Global Cord Blood and other stocks. Vote "Outperform" if you believe CO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CO will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/24/2019 by MarketBeat.com StaffFeatured Article: Why are gap-down stocks important? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.